Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations

Podobne zapisy

• Response to: Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
  od: Citarella, Fabrizio, i wsp.
  Wydane: (2021)
• The Effectiveness of Afatinib in a Patient with Advanced Lung Adenocarcinoma Harboring Rare G719X and S768I Mutations
  od: Watanabe, Masahiro, i wsp.
  Wydane: (2017)
• The Onset of Eosinophilic Pneumonia Preceding Anti-synthetase Syndrome
  od: Hachisu, Yoshimasa, i wsp.
  Wydane: (2017)
• Roles of Cyclic AMP Response Element Binding Activation in the ERK1/2 and p38 MAPK Signalling Pathway in Central Nervous System, Cardiovascular System, Osteoclast Differentiation and Mucin and Cytokine Production
  od: Koga, Yasuhiko, i wsp.
  Wydane: (2019)
• Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients
  od: Hachisu, Yoshimasa, i wsp.
  Wydane: (2019)